Plasminogen Activator Inhibitor Type 1 is the Most Significant of the Usual Tissue Prognostic Factors in Node-Negative Breast Ductal Adenocarcinoma Independent of Urokinase-Type Plasminogen Activator

F. Descotes; B. Riche; S. Saez; G. De Laroche; J. Datchary; P. Roy; P. André; J.-Y. Bobin

hal-00428276, version 1

Plasminogen Activator Inhibitor Type 1 is the Most Significant of the Usual Tissue Prognostic Factors in Node-Negative Breast Ductal Adenocarcinoma Independent of Urokinase-Type Plasminogen Activator

F. Descotes, B. Riche ¹, S. Saez, G. De Laroche, J. Datchary, P. Roy ¹, P. André, J.-Y. Bobin

Clinical Breast Cancer 8(2) (2008) 168-177

1 : Laboratoire de Biométrie et Biologie Evolutive (LBBE)
Université Claude Bernard - Lyon I – CNRS : UMR5558 – INRIA

hal-00428276, version 1
http://hal.archives-ouvertes.fr/hal-00428276
oai:hal.archives-ouvertes.fr:hal-00428276
Contributeur : Stéphane Delmotte <>
Soumis le : Mercredi 28 Octobre 2009, 17:24:10
Dernière modification le : Mercredi 28 Octobre 2009, 17:24:10

Voir la fiche détaillée

Exporter

Bibtex EndNote TEI RefWorks

<?xml version="1.0" encoding="UTF-8"?>
<listBibl xmlns="http://www.tei-c.org/ns/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<listBibl type="article"><head>Articles dans des revues avec comité de lecture</head>
<biblStruct type="article" xml:id="hal-00428276"><analytic>
<author><persName><forename>F.</forename><surname>Descotes</surname></persName></author>
<author><persName><forename>B.</forename><surname>Riche</surname></persName>
<affiliation>
<orgName type="laboratory">LBBE</orgName>
<orgName type="team">Laboratoire de Biométrie et Biologie Evolutive</orgName>
<country>FR</country>
<orgName type="institution">Université Claude Bernard - Lyon I</orgName>
<orgName type="institution">CNRS : UMR5558</orgName>
<orgName type="institution">INRIA</orgName>
</affiliation>
</author>
<author><persName><forename>S.</forename><surname>Saez</surname></persName></author>
<author><persName><forename>G.</forename><surname>De Laroche</surname></persName></author>
<author><persName><forename>J.</forename><surname>Datchary</surname></persName></author>
<author><persName><forename>P.</forename><surname>Roy</surname></persName>
<affiliation>
<orgName type="laboratory">LBBE</orgName>
<orgName type="team">Laboratoire de Biométrie et Biologie Evolutive</orgName>
<country>FR</country>
<orgName type="institution">Université Claude Bernard - Lyon I</orgName>
<orgName type="institution">CNRS : UMR5558</orgName>
<orgName type="institution">INRIA</orgName>
</affiliation>
</author>
<author><persName><forename>P.</forename><surname>André</surname></persName></author>
<author><persName><forename>J.-Y.</forename><surname>Bobin</surname></persName></author>
<title type="main" level="a">Plasminogen Activator Inhibitor Type 1 is the Most Significant of the Usual Tissue Prognostic Factors in Node-Negative Breast Ductal Adenocarcinoma Independent of Urokinase-Type Plasminogen Activator</title></analytic><monogr><title level="j" type="main">Clinical Breast Cancer</title><imprint><biblScope type="publicationDate">2008-00-00</biblScope><biblScope type="vol">8(2)</biblScope><biblScope type="pp">168-177</biblScope></imprint></monogr><idno type="HALid">http://hal.archives-ouvertes.fr/hal-00428276</idno></biblStruct>
</listBibl>
</listBibl>